
Baxter International has announced the continued expansion of its pharmaceuticals portfolio with the launch of five new injectable products in …

Japanese drug firm Eisai Co (TYO: 4523) said it has launched its anticancer agent Lenvima (lenvatinib mesylate) in Mexico. Lenvima …

Diabetes drugmaker Novo Nordisk (NYSE: NYO) said it has secured European Medicines Agency (EMA) marketing approval for its insulin pump. …

Actelion (SIX: ATLN) said its high blood pressure drug Uptravi (selexipag) is now available in Germany. The European Commission granted …

Swiss drug firm Roche (Six: ROG) has launched a blood-clott monitoring system for patients with different heart conditions. The CoaguChek …

You don’t have to look very far to see that the pharma industry business model is under increased pressure, and …
When NASA launches a rocket, most of the hard work is already done. The flight itself is relatively short, yet …
Pharmaceutical companies are increasingly looking to 'managed entry' programmes to build strong relationships with NHS customers and ensure new products …
In 1987 the average cost of development for new pharmaceutical products was $231 million, and it took between 10 and …
The summer period is traditionally a quiet time for the pharmaceutical industry, especially when it comes to product launches.